Cytosorbents (CTSO) Leases (2018 - 2026)

Cytosorbents (CTSO) has 9 years of Leases data on file, last reported at $10.8 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 5.27% year-over-year to $10.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.8 million (down 5.27% YoY), and the FY2025 full-year result was $10.9 million, down 5.1% from the prior year.
• Leases for Q1 2026 stood at $10.8 million, down from $10.9 million in the prior quarter.
• Across five years, Leases topped out at $13.2 million in Q1 2022 and bottomed at $10.8 million in Q1 2026.
• The 5-year median for Leases is $11.9 million (2024), against an average of $11.9 million.
• Peak annual rise in Leases reached 1328.29% in 2022, while the deepest fall reached 6.28% in 2022.
• A 5-year view of Leases shows it stood at $12.6 million in 2022, then dropped by 4.32% to $12.1 million in 2023, then fell by 4.54% to $11.5 million in 2024, then slipped by 5.1% to $10.9 million in 2025, then slipped by 1.42% to $10.8 million in 2026.
• The last three Leases figures came in at $10.8 million (Q1 2026), $10.9 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.

Peer Comparison